Embed Size (px)
Citation preview
1
CURRICULUM VITAE
Herbert H. Schaumburg, M.D.
DATE OF BIRTH: November 6, 1932, Houston, Texas
ADDRESS: Albert Einstein College of Medicine
Business 1300 Morris Park Avenue
Bronx, NY 10461
(718) 430-2002 Fax (718) 430-3664
E Mail: [email protected]
EDUCATION:
St. John’s School, Houston, Texas 1947 - 1952
Harvard College: A.B. cum laude 1956
Washington University, St. Louis, Missouri: M.D. 1960
POST-GRADUATE TRAINING:
Vanderbilt University Hospital: Medical Internship 1961
Bronx Municipal Hospital: Neurology Residency 1961 - 1964
Albert Einstein College of Medicine: Interdisciplinary Fellowship 1964 - 1967
Massachusetts General Hospital: N.I.H. Special Fellowship in Neuropathology 1969 - 1971
PROFESSIONAL EMPLOYMENT AND ACADEMIC APPOINTMENTS:
Instructor in Neurology, Albert Einstein College of Medicine 1964 - 1967
Assistant Professor of Neurology, Albert Einstein College of Medicine 1967 - 1969
Instructor of Pathology, Harvard Medical School 1969 - 1971
Associate Professor of Neurology, Assistant Professor of Pathology,
(Neuropathology) Albert Einstein College of Medicine 1972 - 1976
Deputy Director, Neurology, Bronx Municipal Hospital Center 1972 - 1976
Professor of Neurology, Albert Einstein College of Medicine 1976 - present
Vice Chairman of Neurology, Albert Einstein College of Medicine 1977 - 1984
Associate Professor of Pathology (Neuropathology)
Albert Einstein College of Medicine 1979 - 1984
Co-Director of Neurology, Bronx Municipal Hospital Center 1979 - 1984
Professor of Pathology (Neuropathology), Albert Einstein College of Medicine 1984 - present
2
Medical Director, Institute of Neurotoxicology 1980
Director of Neurology, Bronx Municipal Hospital Center 1983
Interim Chairman of Neurology, Albert Einstein College of Medicine 1984
Chairman of Unified Departments of Neurology
Albert Einstein College of Medicine and Montefiore Medical Center 1986 - 2004
Professor of Neurology and Pathology (Neuropathology),
Albert Einstein College of Medicine and Montefiore Medical Center 2004 - present
BOARD CERTIFICATION:
American Board of Neurology & Psychiatry (Neurology) 1966
PROFESSIONAL SOCIETY MEMBERSHIPS (PRESENT AND PAST):
American Academy of Neurology
American Association of Neuropathologists
American College of Occupational and Environmental Medicine
American College of Medical Toxicology
American Neurological Association
Society of Toxicology
Society for Neuroscience
AWARDS, HONORS, AND RECOGNITION:
Co-recipient, Moore Award - Best Clinical Presentation at the Meeting
of the American Association of Neuropathologists 1975
Recipient, Moore Award - Best Clinical Presentation at the Meeting
of the American Association of Neuropathologists 1976
Elected to the Leo M. Davidoff Society - Albert Einstein College of Medicine
by the class of 1979 in recognition for Excellence in Teaching 1979
Who's Who in America 1987 - present
Honorary Alumnus - Albert Einstein College of Medicine Award in
recognition for his services to the Albert Einstein disabled community 1996
Association of University Professors Award for recruiting the most medical
Students into Neurology 2000
Physician Honoree at the Annual Celebrate Montefiore Banquet,
Waldorf Astoria, N.Y.C. 2004
Recipient of the Lifetime Achievement Award for Excellence in Teaching
Albert Einstein College of Medicine 2012
3
Harry Eagle Award for Outstanding Basic Science Teaching
Albert Einstein College of Medicine 2012
OTHER APPOINTMENTS:
Consultant (Neurotoxicology) - National Institute for Occupational Safety and
Health and the Environmental Protection Agency 1976
Editorial Board - Neurotoxicology 1978 - 1988
Member, Toxic Substances Consultant Registry Panel of the American
Public Health Association 1979
Contributing Editor - American Journal of Industrial Sciences 1980
Safety and Occupational Health Study Section - Centers for Disease Control
(CDC Atlanta) 1980 - 1984
Editorial Board - Annals of Neurology 1981 - 1987
Editorial Board - Journal of the Neurological Sciences 1983 - 1988
Scientific Advisory Board - United Leukodystrophy Foundation 1984 - 1988
Editorial Board- Journal of Neurological Rehabilitation 1986 - 1989
Councilor - American Neurological Association 1986 - 1988
Chairman, Editorial Review Committee - American Neurological Association 1987 - 1988
Editorial Board (Assistant Editor) - Poisindex(R) 1988 - 1997
Editorial Board - Journal of Neurological Sciences 1988 - 1996
Member, Neurology Subcommittee of the AIDS Clinical Trials Group (ACTG) 1987 - 1990
Vice President, American Neurological Association 1989 - 1991
Member, National Advisory Board on Medical Rehabilitation Research, NIH 1991 - 1994
Board of Directors, International Institute for Inhalant Abuse 1994 - 2002
Adjunct Senior Clinical Scientist - Center for Research on Occupational and
Environmental Toxicology 1994 - 1996
Neurotoxicology Consultant, New York Poison Control Center 2006 - Present
4
RESEARCH SUPPORT:
Principal Investigator (RO-1) NIH, Ultrastructural Study of Adrenoleukodystrophy
NINCDS 1977 - 1981
Principal Investigator (RO-1) NIH, Toxicological Study of the Primate CNS
NIEHS 1979 - 1982
Principal Investigator (RO-1) NIH, A Clinical Study of Adrenoleukodystrophy
National Foundation - March of Dimes 1976 - 1980
Co-Principal Investigator, Toxicity of Industrial Chemicals on CNS
NIOSH 1982 - 1985
Co-Principal Investigator, Occupational Neuropathy: Mechanism, Detection,
Treatment - NIOSH 1983 - 1986
Co-Principal Investigator, Neurotoxic Probes of Motor and Sensory System Disease
(Program Project) - NINCDS 1983 - 1986
Principal Investigator (RO-1) NIH, The Effect of an Aldose Reductase Inhibitor on
Painful Diabetic Neuropathy - Pfizer Corporation 1984 - 1985
Principal Investigator (RO-1) NIH, An Investigation of Possible MEK-Toluene
Neurotoxicity in Man - Shell Oil 1985 - 1986
Co-Principal Investigator, An Investigation of Vigabatrin Neurotoxicity in the Dog
Merrill-Dow Corporation 1985 - 1987
Principal Investigator (RO-1) NIH, A Clinical Study of ddC Neuropathy in HIV
Disease - National Institute of Allergy and Infectious Disease
(Hoffmann-La Roche) 1987- 1989
Principal Investigator (RO-1) NIH, The Effect of an Aldose Reductase Inhibitor on
Diabetic Sensory Neuropathy - Stuart Pharmaceuticals – ICI 1984 - 1988
Principal Investigator (RO-1) NIH, Rehabilitation of Spasticity in Spinal Cord
Disorders - National Institute of Handicapped Research - U.S. Department
of Education 1987 - 1990
Co-Principal Investigator, Toxicity of Dideoxycytidine in the Primate
Hoffmann-La Roche 1988 - 1990
Principal Investigator (RO-1) NIH, A clinical study of ddI Neuropathy
National Institute of Allergy and Infectious Disease
(Bristol-Myers Corporation) 1989 - 1990
Co-Principal Investigator, A Randomized Multicenter Placebo-Controlled Dose
5
Finding/Efficacy/Safety Study of ORG 2766 in Prevention or Delay of
Cisplatin Induced Neuropathies in Patients with Ovarian Cancer
Organon, Inc. (Akzo Pharma Division) 1990 - 1991
Co-Principal Investigator, Protocol for a randomized, double blind, placebo-controlled,
group comparative study to evaluate the effect on neuropathy-free interval of
2 mg ORG 2766 s.c. before and after every cytostatic treatment course in 120
patients with (non)-Hodgkin lymphoma treated with vincristine
Organon International B.V., The Netherlands 1991 - 1992
Co-Principal Investigator, Peripheral Neuropathy in HIV Drug Abusers
NIDA 1991 - 1994
Investigator (RO-1) (Joseph Arezzo, P.I), Electrophysiologic Measurements
in Diabetic Neuropathy - NIDDK 2005 - 2008
Co-Principal Investigator, Toxicity of Nemifitide in Dogs and Primates
Tetragenix Pharma 2005 - 2007
Co-Principal Investigator, Toxicity of Edaravone in the Primate
Mitsubishi Pharma 2005 - 2007
Co-Principal Investigator,Toxicity of Adenosine Nucleoside
Burroughs Wellcome
Co-Principal Investigator, A Six-Month Oral Toxicity Study in Cynomolgus
Monkeys - Burroughs Wellcome
Co-Principal Investigator, A 28-Day Oral Toxicity Study of Cynomolgus Monkeys
Burroughs Wellcome
VISITING LECTURESHIPS AND INVITED PAPERS PRESENTED AT NATIONAL AND
INTERNATIONAL MEETINGS AND SYMPOSIA (1978-2009):
1978: Invited Lecturer, University of New Mexico, Albuquerque, USA
Invited participant - New York Academy of Sciences Symposium on Public Control of
Environmental Health Hazards, USA
Invited Lecturer and Visiting Professor - Montreal General and Montreal Children’s Hospital,
Canada
Invited participant - Course on Peripheral Nerve Disorders, American Academy of Neurology,
USA
Invited participant - Symposium on Neurotoxicology, Third International Congress on
Neuromuscular Disease, Montreal, Canada
1979: Invited Lecturer - Neurological Institute, College of Physicians & Surgeons, USA
Invited keynote speaker - Symposium on Neurotoxicology at Sixth International Congress of
Electromyography, Stockholm, Sweden
6
Director of Symposium and invited lecturer - International Congress of Neurotoxicology,
Varese, Italy
Invited participant - Peripheral Nerve Study Group, Wye College, Wye, England
EPA and S.W. Foundation Conference on Tests for Toxic Effects on Behavioral and
Neuromotor Function, USA
1980: Invited participant - Toxicology Forum Symposium on Neurotoxicology, USA
Grand Rounds and Visiting Professor - N.Y. University, Bellevue Medical Center
Grand Rounds and Visiting Professor - N.Y. Hospital, Cornell Medical Center, USA
Invited participant - University of Minnesota Symposium on Environmental Pathology and
Toxicology, USA
Invited Lecturer - Massachusetts Institute of Technology, USA
Invited Lecturer and Visiting Professor - Toronto General Hospital, Toronto, Canada
1981: Invited participant - Peripheral Nerve Study Group, USA
Invited participant - A.L.S. Symposium, Muscular Dystrophy Association, USA
Invited Lecturer - University of Basle, Switzerland
Ground Rounds and Visiting Professor - New York Neurological Institute
Invited participant - Symposium on Clioquinol Neurotoxicology, Geneva, Switzerland
Invited participant - Rockefeller University Symposium on Health Effects of Chemical Disposal
Sites, USA
1982: Invited Participant - Symposium on Hazards of Toxic Waste Disposal Sites, EPA-NIEHS, USA
Invited Lecturer- All India Institute of Toxicology, Lucknow, India
International Neuropathology Symposium, Kyoto, Japan
Director and Organizer - Neurotoxicology Course, American Academy of Neurology, USA
Invited participant - International Symposium on Motor Neuron Disease, London
Invited participant - American Petroleum Institute Symposium on Hydrocarbon Neurotoxicity,
USA
1983: Invited Lecturer and Head of EPA Site Visit Team - University of Alexandria, Egypt
Invited Keynote Lecturer - Swedish Neurotoxicology Symposium, Copenhagen, Denmark
Invited Lecturer - XI Pan-American Congress of Biochemistry and Pharmacology, Lima, Peru
Chairman and Organizer - Neurotoxicology Course, American Academy of Neurology, USA
Invited participant - NIOSH/World Health Organization Workshop on Occupational
Neurotoxicology, USA
Chairman and Co-Organizer - EPA Workshop on Environmental Neurotoxicology, USA
Invited Lecturer - Danish Neurological Society, Copenhagen, Denmark
Organizer and participant - Peripheral Neuropathy Symposium - American Neurological
Association Annual Meeting, USA
Invited participant - Peripheral Nerve Study Group - Fontevraud, France
Invited Lecturer - Toxicology Forum International Meeting, Geneva, Switzerland
Invited Lecturer - Second International Conference on Neurotoxicology of Selected Chemicals,
USA
Invited Lecturer - National Institute of Environmental Sciences Conference on Potential Health
Effects of Polychlorinated Biphenyls, USA
1984: Invited Lecturer - Neurotoxicology Symposium: Annual Meeting of American Association of
Electromyography, Kansas, USA.
7
Grand Rounds and Visiting Professor - Mt. Sinai Hospital and Medical School, NY
Invited Lecturer - Occupational Medical Society, Chicago
Chairman and Organizer - Neurotoxicology Course, American Academy of Neurology, USA
Keynote Speaker - Emory University, Georgia Neurological Society, Atlanta
Invited participant - Basic Mechanism Symposium, Society of Toxicology Annual Meeting,
Atlanta
1985: Grand Rounds and Visiting Professor - University of Chicago
Invited Lecturer - University of California, San Diego
Grand Rounds and Visiting Professor - University of Colorado Medical Center, Denver
Organizer and participant - Neurotoxicology Symposium, Xth World Congress of Neurology,
Hamburg, Germany
Invited participant - Peripheral Nerve Symposium, Xth World Congress of Neurology, Hamburg,
Germany
Organizer and Participant - II International Congress of Neurobehavioral Toxicology,
Copenhagen, Denmark
Grand Rounds and Visiting Professor - Salt Lake City
Grand Rounds and Visiting Professor - New Jersey School of Medicine and Dentistry,
Piscataway, New Jersey
1992: Grand Rounds and Visiting Lecture - Massachusetts General Hospital
Grand Rounds and Visiting Professor - University of Connecticut
Invited Lecturer and Visiting Professor - University of Utah, Salt Lake City
Lecture - Lenox Hill Hospital, New York
Medical Grand Round Lecture - Long Island Jewish Hospital, New York
Invited Lecturer - International AIDS Symposium, Amsterdam
Invited Lecturer - Spaulding Memorial Hospital/Harvard Rehabilitation, Boston, Massachusetts
Invited Lecturer - Burke Hospital, White Plains, New York
Co-Chairman and Organizer - Occupational Neurology and Neurotoxicology Course, American
Academy of Neurology, San Diego, California
Invited participant - American Academy of Neurology Course on Peripheral Neuropathy, San
Diego, California
1994: Wartenberg Lecture - American Academy of Neurology, New York
2003: Morton Nathanson Lecture - Long Island Jewish Medical Center
Grand Rounds and Visiting Professor - N.Y. Hospital Cornell Medical Center
2004: Chairman and Organizer of Neurotoxicology Course at Annual Meeting of the American
Academy of Neurology, San Francisco, California
Grand Rounds and Visiting Professor - Stony Brook Campus of State University of N.Y.
2006: Chairman, Organizer, and Principal Speaker - Neurotoxicology course at the Annual Meeting
of the American Academy of Neurology, April, 4, 2006, San Diego
Invited Lecturer - “Pathophysiology of toxic neuropathies” at the Annual Meeting of the
American Association of Neuromuscular Diseases and Electrophysiological Medicine,
October 14, 2006, Washington D.C.
8
2007: Chairman, Organizer, and Principal Speaker - Neurotoxicology course at the Annual Meeting of
the American Academy of Neurology, April, 4, 2007, Boston
2008: Invited Lecturer and participant-Toxicology Symposium at the Annual Meeting of the American
Academy of Occupational Medicine, April 15, 2008, New York
Grand Rounds and Visiting Professor - New York University School of Medicine
Invited Lecturer - “Toxic Encephalopathies,” New York Poison Control Center
Invited Lecturer - “Toxic Neuropathies” at the Annual Meeting of the American Academy of
Occupational and Environmental Medicine
2009: Invited Keynote Speaker - “Toxicant-Induced Parkinsonism” and “Toxicant-Induced Peripheral
Neuropathy” at the Annual American College of Medical Toxicology Spring Conference,
March 27, 2009, San Juan, Puerto Rico
2011: Invited grand rounds speaker at NY Presbyterian Hospital and at the New York Mount Sinai
Medical Center
2012: Chairman and organizer of the Neurotoxicology Course at the Annual Meeting of the American
Neurological Association, April 22, 2012, New Orleans, LA.
RESEARCH ACTIVITIES:
1. Neurotoxic disease - Dr. Schaumburg, in collaboration with Drs. Peter Spencer, Cedric Raine and
Joseph Arezzo at Albert Einstein and with Professor P.K. Thomas at the Royal Free Hospital in London,
has conducted and is currently performing several ultrastructural and electrophysiological studies of
nervous system disease produced by neurotoxins in primates and dogs. In addition to experimental
studies, he is pursuing federally funded clinical studies designed to help in the early detection of nervous
system disease among individuals exposed to neurotoxins in the workplace and directs the
Neurotoxicology Clinical Center at Montefiore Medical Center to evaluate such persons.
2. Adrenoleukodystrophy - Dr. Schaumburg has investigated both clinical and morphological aspects
of adrenoleukodystrophy. He has conducted an electron microscopic examination of serial sections of
the demyelinating lesions in ALD to determine both the role of the lymphocytes and the nature of the
oligodendrocyte reaction in this condition.
3. Peripheral Neuropathy - Dr. Schaumburg is Co-Director of the Neuromuscular Division of the
Neurology Department and supervises the weekly neuromuscular conference. He has written a well-
received textbook on Diseases of Peripheral Nerve, now in its third edition (Oxford University Press
2110) and has written the chapters on peripheral neuropathy in Editions 17 and 18 of Cecil's Textbook
of Medicine. Dr. Schaumburg has also co-authored the chapters on Industrial Toxins and
Pharmaceutical Agents in the 4th
edition of Peripheral Neuropathy (Dyck & Thomas eds., Elsevier
Press, 2005). Dr. Schaumburg, in concert with Dr. Arezzo, has designed and developed several
diagnostic instruments for testing sensory dysfunction (Vibratron, thermal device). Dr. Schaumburg has
been the Principal Investigator of a clinical study of the efficacy of aldose reductase inhibitors in treating
painful diabetic neuropathy, two studies of nucleoside neuropathy in AIDS patients, and a clinical study
of an outbreak of peripheral neuropathy in workers at the Shell Oil Refinery in Deer Park, Texas. He
and Dr. Alan Berger and Dr. Joseph Arezzo established a Sensory Motor Evaluation Center and a
Neuromuscular Center at Montefiore Medical Center to evaluate peripheral nerve disease and to act as a
9
resource service for the institution.
CLINICAL, TEACHING AND NEUROTOXIC PUBLIC INTEREST ACTIVITIES:
1. General Neurology - Dr. Schaumburg, as Chairman of the Neurology Service at Jacobi Medical
Center and Montefiore Medical Center, presides over weekly grand rounds and clinical conferences. He
also is an attending physician for two months of every year.
2. Clinical Neurotoxicology - Dr. Schaumburg, as Director of the Neurotoxicology Clinical Center,
evaluates and treats many individuals with neurotoxic illness. He has consulted on diverse intoxications
including: toluene, ddC, taxol, ethylene oxide, cisplatin, vincristine, cyanide, carbon monoxide,
mercury, cadmium, nitrous oxide, n-hexane, acrylamide, pyridoxine, pyrethrum, ciguatera, lathyrus, and
organophosphate intoxication. Publications have resulted from many of these cases.
3. Medical Undergraduate Teaching - Dr. Schaumburg is responsible for the peripheral neuropathy
and neurotoxicology section of the second year Nervous System Pathophysiology course at Albert
Einstein. In recognition for excellence in teaching, the undergraduates elected Dr. Schaumburg to the
Leo M. Davidoff Society in 1979.
4. American Academy of Neurology Course in Neurotoxicology - Dr. Schaumburg directs, organizes
and participates in the Neurotoxicology Course at the Annual Meeting of the American Academy of
Neurology.
5. Textbooks - Dr. Spencer and Dr. Schaumburg edited the first comprehensive (925 pages) textbook
on Neurotoxicology - Experimental and Clinical Neurotoxicology, 1980, Williams and Wilkins.
Oxford University Press published the second edition of this textbook in March 2000. Dr. Schaumburg,
assisted by Drs. Spencer and P.K. Thomas, has written a 241-page textbook Disorders of Peripheral
Nerve, published by F.A. Davis in 1983 as Volume 24 in the Contemporary Neurology Series. A second
edition appeared in 1991 as Volume 36 in the Contemporary Neurology Series and a third edition (now
entitled as: Peripheral Neuropathies in Clinical Practice) has recently been published (2110, Oxford
University Press).
6. Public Service
Served as vestryman, then senior warden, of Grace Church (Episcopal) 1974 - 1978
Served on the Board of Directors of Morningside House, a skilled nursing facility
affiliated with the Grace Episcopal Church 1989 - 1991
Invited to be a participant of an expert panel at the National Institutes of
Health Technology Workshop on Gulf War Syndrome 1994
Invited speaker at the National Institutes of Health Symposium on
the Risks and Benefits of Thalidomide Therapy 1997
ORIGINAL COMMUNICATIONS IN REVIEWED JOURNALS:
1. Weitzman, E., Schaumburg, H.H. and Fishbein, W.: Plasma 17-hydroxycorticosteroid level
during sleep in man. Journal of Clinical Endocrinology and Metabolism, 26:121-127, 1966.
2. Fishbein, W., Schaumburg, H.H. and Weitzman, E.: Rapid eye movements during sleep
in dark reared kittens. Journal of Nervous and Mental Disease, 143:281-282, 1966.
10
3. Schaumburg, H.H., Byck, R., Herman, R. and Rosengart, C.: Peripheral nerve damage
by cold. Archives of Neurology, 16:103-110, 1967.
4. Herman, R. and Schaumburg, H.H.: Dynamic and static sensitivity of the stretch reflex
in spastic cerebral palsy. Developmental Medicine and Child Neurology, 9:487-492,
1967.
5. Herman, R., Schaumburg, H.H. and Reiner, S.: A rotational joint apparatus: a device
for study of tension-length relations of human muscle. Medical Research Engineering,
4:18-20, 1967.
6. Schaumburg, H.H. and Herman, R.: Studies of the human stretch reflex. Journal of the
Neurological Sciences, 7:189-191, 1968.
7. Herman, R. and Schaumburg, H.H.: Alterations in dynamic and static properties of the
stretch reflex in patients with spastic hemiplegia. Archives of Physical Medicine and
Rehabilitation, 49:199-203, 1968.
8. Schaumburg, H.H. and Suzuki, K.: Nonspecific familial presenile dementia. Journal of
Neurology, Neurosurgery and Psychiatry, 31:479-486, 1968.
9. Schaumburg, H.H., Byck, R., Gerstl, R. and Mashman, J.: Monosodium 1-glutamate:
Its pharmacology and role in the Chinese restaurant syndrome. Science, 163:262-282,
1969.
10. Schaumburg, H.H., Byck, R. and Weller, R.: The effects of phenol on peripheral nerve.
Journal of Neuropathology and Experimental Neurology, 29:615-630, 1970.
11. Schaumburg, H.H., Nielsen, S. and Yurchak, P.M.: Heart block in polymyositis. New
England Journal of Medicine, 284:48-49, 1971.
12. Herskowitz, A., Ishii, N. and Schaumburg, H.H.: n-Hexane neuropathy. New England
Journal of Medicine, 285:82-85, 1971.
13. Schaumburg, H.H., Plank, C. and Adams, R.D.: The reticulum cell sarcoma-
microglioma group of brain tumors. Brain, 95:199-212, 1972.
14. DeReuck, J. and Schaumburg, H.H.: Periventricular atheosclerotic
leukoencephalopathy. Neurology, 22:1094-1077, 1972.
15. Byck, R., Goldfarb, J., Schaumburg, H.H. and Sharpless, S.: Reversible differential
block of Saphenous nerve by cold. Journal of Physiology, 222:17-26, 1972.
16. Walpow, E. and Schaumburg, H.H.: The human arachnoid villus. Journal of
Neurosurgery, 37:724-727, 1972.
17. Woods, B. and Schaumburg, H.H.: Nigro-spino-dentatal degeneration with nuclear
ophthalmoplegia. Journal of the Neurological Sciences, 17:149-166, 1972.
11
18. Schaumburg, H.H., Richardson, E.P., Johnson, P.S., Cohen, R.D., Powers, J. and Raine,
C.: Schilder's disease: Sex-linked recessive transmission with specific adrenal changes.
Archives of Neurology, 27:458-460, 1972.
19. Horoupian, D., Powers, J.M. and Schaumburg, H.H.: Kuru-like neuropathological
changes in a North American. Archives of Neurology, 17:555-561, 1972.
20. Lipinski, J.F., Schaumburg, H.H. and Baldessarini, R.H.: Regional distribution of
histamine in human brain. Brain Research, 51:53-58, 1973.
21. Spencer, P.S. and Schaumburg, H.H.: An ultrastructural study of the inner core of the
Pacinian corpuscle. Journal of Neurocytology, 2:217-235, 1973.
22. Powers, J.M. and Schaumburg, H.H.: The adrenal cortex in adrenoleukodystrophy.
Archives of Pathology, 96:305-310, 1973.
23. Powers, J.M. and Schaumburg, H.: Adrenoleukodystrophy: Similar ultrastructural
changes in Adrenal cortical and Schwann cells. Archives of Neurology, 30:406-408,
1974.
24. Schaumburg, H.H., Wisniewski, H. and Spencer, P.S.: Ultrastructural studies of the
dying-back process. I.Peripheral nerve terminal and axon degeneration in systemic
acrylamide intoxication. Journal of Neuropathology and Experimental Neurology,
33:260, 1974.
25. Herbstein, D. and Schaumburg, H.: Hypertensive intracerebral hematoma. An
investigation of the initial hemorrhage and rebleeding using Cr51 labeled erythrocytes.
Archives of Neurology, 30:412-414, 1974.
26. Powers, J.M., Horoupian, D.S. and Schaumburg, H.H.: Wetherbee Ail. Canadian
Journal of The Neurological Sciences, 1:139-140, 1974.
27. Spencer, P.S., Schaumburg, H.H., Raleigh, R.I. and Terhaar, C.J.: Nervous system
regeneration produced by the industrial solvent methyl n-butyl ketone. Archives of
Neurology, 32:219, 1975.
28. Powers, J.M. and Schaumburg, H.H.: Adrenoleukodystrophy (Sex-linked Schilder's
disease): A pathogenetic hypothesis based on ultrastructural lesions in adrenal cortex,
peripheral nerve, and testis. American Journal of Pathology, 76:481-492, 1975.
29. Raine, C.S., Schaumburg, H.H., Snyder, D.H. and Suzuki, K.: The nonspecificity of
tranuclearparamyxovirus-like material for multiple sclerosis. Journal of the Neurological
Sciences, 25:29-41, 1975.
30. Spencer, P.S. and Schaumburg, H.H.: Nervous system dying-back disease produced by
2, 4-hexanedione. Transactions of the American Neurological Association, 100:148,
1975.
12
31. Schaumburg, H.H., Powers, J.M., Raine, C.S., Suzuki, K. and Richardson, E.P.:
Adreno-leukodystrophy: A clinical and pathological study of seventeen cases. Archives
of Neurology, 32:577-591, 1975.
32. Spencer, P.S. and Schaumburg, H.H.: Nervous system degeneration produced by
acrylamidemonomer. Environmental Health Perspectives II: 129-122, 1975.
33. Schaumburg, H.H. and Spencer, P.S.: Central and peripheral nervous system
degeneration produced by pure n-hexane. Transactions of the American Neurological
Association, 101:153-156, 1976.
34. Spencer, P.S. and Schaumburg, H.H.: Experimental neuropathy produced by 2,5-
hexanedione, a major metabolite of the neurotoxic industrial solvent methyl n-butyl
ketone. Journal of Neurology, Neurosurgery and Psychiatry, 38:771-774, 1975.
35. Schaumburg, H.H. and Spencer, P.S.: Degeneration in central and peripheral nervous
system produced by pure n-hexane: An experimental study. Brain, 99:183-192, 1976.
36. Johnson, A.B., Schaumburg, H.H. and Powers, J.M.: Histochemical characteristics of
the lipid inclusions in adrenoleukodystrophy. Journal of Histochemistry and
Cytochemistry, 24:725-730, 1976.
37. Spencer, P.C. and Schaumbug, H.H.: Ultrastructural studies of the dying-back process.
III. The evolution of experimental giant axonal degeneration. Journal of Neuropathology
and Experimental Neurology, 36:276-299, 1977.
38. Spencer. P.C. and Schaumburg, H.H.: Ultrastructural studies of the dying-back process.
IV. Differential vulnerability of PNS and CNS fibers in experimental and central-
peripheral distal axonopathies. Journal of Neuropathology and Experimental
Neurology, 36:300-320, 1977.
39. Spencer, P.S. and Schaumburg, H.H.: Feline nervous system response to chronic
intoxication With commercial grades of methyl n-butyl ketone, methyl isobutyl ketone
and methyl ethyl ketone. Toxicology and Applied Pharmacology, 37:301-307, 1976.
40. Wray, S.H., Cogan, D.G., Kuwabra, T., Schaumburg, H.H. and Powers, J.M.:
drenoleukodystrophy with pathology of the eye and optic nerve. American Journal of
Ophthalmology, 82:480-484, 1976.
41. Igarashi, M., Schaumburg, H.H., Powers, J., Kishimoto, Y., Kolodny, E. and Suzuki,
K.: Fatty Acid abnormality in adrenoleukodystrophy. Journal of Neurochemistry,
26:851-860, 1976.
42. Spencer, P.S. and Schaumburg, H.H.: Neurotoxic properties of certain aliphatic
hexacarbons. Proceedings of the Royal Society of Medicine, 70:37-40, 1977.
43. Griffin, J.W., Goren, E., Schaumburg, H.H., Engel, W.K. and Loriaux, L.:
drenomyeloneuropathy. A probable variant of adrenoleukodystrophy. I. Clinical and
endocrinological aspects. Neurology, 27:1107-1113, 1977.
13
44. Schaumburg, H.H., Powers, J.M., Raine, C.S., Spencer, P.S., Griffin, J.W., Prineas,
J.W. and Boehme, D.M.: Adrenomyeloneuropathy. A probable variant of
adrenoleukodystrophy. II. General pathologic, neuropathologic and biochemical aspects.
Neurology, 27:1114-1119, 1977.
45. Spencer, P.S., Bischoff, M.C. and Schaumburg, H.H.: On the specific molecular
configuration of neurotoxic aliphatic hexacarbon compounds causing central-peripheral
distal axonopathy. Toxicology and Applied Pharmacology, 44:17-28, 1978.
46. Schaumburg, H.H. and Spencer, P.S.: Environmental hydrocarbons produce
degeneration in Cat hypothalamus and optic tract. Science, 199:199-200, 1978.
47. Spencer, P.S. and Schaumburg, H.H.: Distal axonopathy - one common type of
neurotoxic lesion. Environmental Health Perspectives, 26:97-105, 1978.
48. Goldman, J.E., Schaumburg, H.H. and Norton, W.T.: Isolation and characterization of
glial filaments from human brain. Journal of Cell Biology, 78:426-440, 1978.
49. Kawamura, M., Moser, A.B., Moser, H.W., Ogino, T., Suzuki, K., Schaumburg, H.,
Milunsky, A., Murphy, J. and Kishimoto, Y.: High concentration of hexacosanoate in
cultured fibroblast lipids from adrenoleukodystrophy patients. Biochemical and
Biophysical Research Communications, 82:114-120, 1978.
50. Schaumburg, H.H. and Spencer, P.S.: Clinical and experimental studies of distal
axonopathy - a frequent form of nerve and brain damage produced by environmental
chemical hazards. Annals of the New York Academy of Sciences, 329:14-29, 1979.
51. Spencer, P.S., Sabri, M.I., Schaumburg, H.H. and Moore, C.: Does a defect of energy
metabolism in the nerve fiber underlie axon degeneration in polyneuropathies? Annals
of Neurology, 5:501-507, 1979.
52. Schaumburg, H.H. and Spencer, P.S.: Toxic models of certain disorders of the nervous
system - A teaching monograph. Neurotoxicology 1:209-220, 1979.
53. Krinke, G., Schaumburg, H.H., Spencer, P., Thomann, P. and Hess, R.: Clioquinol and
2,5-hexanedione induce different type of distal axonopathy in the dog. Acta
Neuropathologicsa, 47:213-221, 1979.
54. Baumgautner, G., Gawel, M.J., Kaeser, H.E., Pallis, C.A., Rose, F.C., Schaumburg,
H.H., Thomas, P.K. and Wadia, N.H.: Neurotoxicity due to halogenated
hydroxyquinolines. Journal of Neurology, Neurosurgery and Psychiatry, 42:1073-1083,
1979.
55. Moser, H., Moser, A., Kawamura, N., Murphy, J., Milunsky, A., Suzuki, K., and
Schaumburg, H.H: Adrenoleukodystrophy: Elevated C26 fatty acid in cultured skin
fibroblasts. Annals of Neurology, 7:542-549, 1980.
56. Cho, E.S., Spencer, P.S., Jortner, B.S. and Schaumburg, H.H.: A single intravenous
14
injection of Doxorubicin (AdriamycinR) induces sensory neuronopathy in rats.
Neurotoxicology, 1:583, 1980.
57. Schaumburg, H.H.: Morphological studies of toxic distal axonopathy. Neurobehavioral
Toxicology, 1:187 188, 1979.
58. Sterman, A.B., Schaumburg, H.H. and Asbury, A.K.: The acute sensory neuronopathy
syndrome. Annals of Neurology, 7:354-358, 1979.
59. Sterman, A.B., and Schaumburg, H.H.: The role of the cranial CAT scan in municipal
hospitals. American Journal of Public Health, 70:268-270, 1980.
60. Markowitz, L. and Schaumburg, H.H.: Successful treatment of inorganic mercury
neurotoxicity within acetyl-penicillamine despite an adverse reaction. Neurology,
39:1000-1003, 1980.
61. Krinke, G., Schaumburg, H.H., Spencer, P.S., Suter, Y., Thomann, G. and Hess, R.:
Pyridoxine megavitaminosis produces degeneration of peripheral sensory neurons
(sensory neuronopathy) in the dog. Neurotoxicology, 2:13-25, 1981.
62. Arezzo, J.C. and Schaumburg, H.H.: The use of the optacon as a screening device: A
new technique for detecting sensory loss in individuals exposed to neurotoxins. Journal
of Occupational Medicine, 22:461-464, 1980.
63. Powers, J.M., Schaumburg, H.H. and Gaffney, C.L.: Kluver-Bucy syndrome caused by
adrenoleukodystrophy. Neurology, 30:1231-1233, 1980.
64. Powers, J.M. and Schaumburg, H.H.: A fatal cause of sexual inadequacy in the male:
Adrenoleukodystrophy. Journal of Urology, 124:583-586, 1980.
65. Powers, J.M., Raine, C.S., Johnson, .B. and Schaumburg, H.H.: A correlative study of
the adrenal cortex in adrenoleukodystrophy: Evidence for a fatal intoxication with long
chain saturated fatty acids. Investigative & Cell Pathology, 3:353-376, 1980.
66. Egan, G., Spencer, P., Schaumburg, H., Murray, K.J., Bischoff, M. and Scala, R.: n-
Hexane-"free" hexane mixture fails to produce system damage. Neurotoxicology, 1:515-
524, 1980.
67. Powers, J.M. and Schaumburg, H.H.: The testis in adrenoleukodystrophy. Am. J.
Path., 83:90-98, 1981.
68. Arezzo, J.C., Schaumburg, H.H. and Spencer, P.S.: Structure and function of the
somatosensory system. A neurotoxicological perspective. Environmental Health
Perspective, 44:23-30, 1982.
69. Arezzo, J.C., Schaumburg, H.H., Vaughan, Jr. H.G., Spencer, P.S., and Barna, J.:
Hindlimb somatosensory evoked potentials in the monkey: The effects of distal
axonopathy. Annals of Neurology, 12:24-32, 1982.
15
70. Schaumburg, H.H., Spencer, P.S. and Arezzo, J.C.: Monitoring potential neurotoxic
effects of hazardous waste disposal. Environmental Health Perspectives, 48:61-64, 1983.
71. Powers, J.M., Moser, H.M., Moser, A.B. and Schaumburg, H.H.: Fetal
adrenoleukodystrophy: The significance of pathologic lesions in adrenal gland and testis.
Human Pathology, 13:1013-1019, 1983.
72. Moser, H., Migdon, B., Powers, J., Moser, A., Nitowsky, H., Schaumburg, H.H. and
Norum, R.: The prenatal diagnosis of adrenoleukodystrophy: Demonstration of
increased hexacosanoic acid levels in cultured aminocytes and fetal adrenal gland.
Pediatric Research, 16:172-175, 1982.
73. Arezzo, J.C., Schaumburg, H.H. and Peterson, C.: Rapid screening for peripheral
neuropathy: A field study with the Optacon. Neurology, 33:626-629, 1983.
74. Schaumburg, H.H., Kaplan, J., Vick, N., Rasmus, S., Windebank, A., Pleasure, D. and
Brown, M.: Sensory neuropathy from pyridoxine abuse: A new megavitamin syndrome.
New England Journal of Medicine, 309:445-448, 1983.
75. Spencer, P.S. and Schaumburg, H.H.: Lathyrism: A neurotoxic disease.
Neurobehavioral Toxicology and Teratology, 5:625-629, 1983.
76. Spencer, P.S. and Schaumburg, H.H.: An expanded classification of neurotoxic
diseases based on cellular targets of chemical agents. Acta neurologica Scandinavica,
7:9-20, 1984.
77. Schaumburg, H.H., Spencer, P.S. and Arezzo, J.: Studies of the primate somatosensory
system In experimental acrylamide intoxication. Neurotoxicology, 1984.
78. Thomas, P.K., Bradley, D., Bradley, W.A., Degen, P.H., Krinke, G., Muddle, J.,
Schaumburg, H.H., Skelton-Stroud, P.M., Thomann, P. and Tzebelikos, E.: Correlated
nerve conduction, somatosensory evoked potential and neuropathological studies in
clioquinol and 2,5 hexanedione. Journal of Neurological Sciences, 64:277-295, 1984.
79. Thomas, P.K., Schaumburg, H.H., Spencer, P.S., Kaeser, H.E., Pallis, C.S., Rose, F.C.
and Wadia, N.H.: The central distal axonopathy syndrome: Newly recognized models of
naturally occurring human disease. Annals of Neurology, 15:313-316, 1984.
80. Kaplan, J., Schaumburg, H.H. and Sumner, A.: Relapsing ophthalmoparesis-sensory
neuropathy syndrome. Neurology, 35:595-597, 1985.
81. Windebank, A.J., Lou, P.A., Blexrud, M.D., Schmelzer, J.D. and Schaumburg, H.H.:
Pyridoxine neuropathy in rats: Specific degeneration of sensory axons. Neurology,
35:1617-1622, 1985.
82. Spencer, P.S. and Schaumburg, H.H.: Organic solvent neurotoxicity. Scandinavian
Journal of Work, Environment & Health, 11:53-60, 1985.
83. Spencer, P.S., Ludolph, A., Dwivedi, M.P., Roy, D., Hogan, J. and Schaumburg, H.H.:
16
Lathyrism: Evidence for role of neuroexcitatory amino acid BOAA. Lancet, 1066-67,
1986.
84. Arezzo, J.C., Schaumburg, H.H., Laudadio, C.: Thermal sensitivity tester. Diabetes,
35:590-592, 1986.
85. Schaumburg, H.H. and Spencer, P.S.: Recognizing neurotoxic disease. Neurology,
37(2):276-279, 1987.
86. Crystal, H.A., Schaumburg, H.H., Grober, E., Fuld, P.A. and Lipton, R.B.: Cognitive
impairment and sensory loss associated with chronic low level ethylene oxide exposure.
Neurology, 38:567-569, 1988.
87. Lipton, R.B., Galer, B.S., Dutcher, J.P., Portenoy, R.K., Berger, A., Arezzo, J.C.,
Mizruchi, M., Wiernik, P.H. and Schaumburg, H.H.: Quantitative sensory testing
demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer.
Arch. Neurol., 44: 944-946, 1987.
88. Arezzo, J.C. and Schaumburg, H.H.: Office and Field Diagnosis of Neurotoxic
Disease. Journal of Clinical Toxicology, 1988.
89. Kaplan, J.G., Pack, D., Horoupian, D., DeSouza, T., Brin, M. and Schaumburg, H.H.:
Distal axonopathy associated with chronic gluten enteropathy: A treatable disorder.
Neurology, 38:642-645, 1988.
90. Hugon, J., Ludolph, A., Roy, D.N., Schaumburg, H.H. and Spencer, P.S.: Studies on
the etiology and pathogenesis of motor neuron diseases. II. Clinical and
electrophysiologic features of pyramidal dysfunction in macaques fed Lathyrus sativus
and IDPN. Neurology, 38:435-442, 1988.
91. Berger, A.R. and Schaumburg, H.H.: Rehabilitation of focal nerve injuries. Journal of
Neurologic Rehabilitation, 2:65-91, 1988.
92. Rosenberg, N.L., Spitz, M.C., Filley, C.M., Davis, K.A. and Schaumburg, H.H.:
Central nervous system effects of chronic toluene abuse - clinical, brainstem evoked
response and magnetic resonance imaging studies. Neurotoxicology and Teratology,
10:489-495, 1988.
93. Lipton, R.B., Apfel, S., Dutcher, J.P., Rosenberg, R., Kaplan, J., Berger, A., Einzig, A.I.,
Wiernik, P. and Schaumburg, H.H.: Taxol produces a predominantly sensory
neuropathy. Neurology, 39:368-373, 1989.
94. Merigan, T.C., Skowron, G., Bozzette, S., Richman, D., Uttamachandani, T., Fischl, M.,
Schooley, R., Hirsch, M., Soo, W., Pettinelli, C. and Schaumburg, H.H.: Circulating
p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus
(HIV) infections. Annals of Internal Medicine, 110: (3) 189-194, 1989.
95. Schaumburg, H.H., Arezzo, J.C. and Spencer, P.S.: Delayed onset of distal axonopathy
in primates following prolonged low-level intoxication with acrylamide. Annals of
17
Neurology, 26:576-579, 1989.
96. Kaplan, J.G., Rosenberg, R., Reinitz, E., Buchbinder, S. and Schaumburg, H.H.:
Invited review: Peripheral neuropathy in Sjögren’s syndrome. Muscle & Nerve, 570-
579, 1990.
97. Berger, A.R., Schaumburg, H.H., Schroeder, C., Apfel, S. and Reynolds, R.: Dose
response, coasting, and differential fiber vulnerability in human neuropathy: A
prospective study of pyridoxine neurotoxicity. Neurology, 42:1367-1370, 1992.
100. Anderson, T.D., Davidovich, A., Arceo, R., Brosnan, C., Arezzo, J. and Schaumburg,
H.: Peripheral neuropathy induced by 2',3'-dideoxycytidine. A rabbit model of 2',3'-
dideoxycytidine neurotoxicity. Laboratory Investigation, 66(1): 63-74, 1992.
101. Schaumburg, H.H. and Berger, A.: Alopecia and sensory polyneuropathy from
thallium in a Chinese herbal medication. Journal of the American Medical Association,
Dec. 23/30, 268:3430-3431, 1992.
102. Jungreis, A.C. and Schaumburg, M.D.: Encephalopathy from abuse of bismuth
subsalicylate (Pepto-Bismol). Neurology, 43(6):1265, 1993.
103. Skowron, G., Bozzette, S.A., Lim, L., Pettinelli, C.B., Schaumburg, H.H., Arezzo, J.
et al.: Alternating and intermittent regimens of zidovudine and dideoxycytidine in
patients with AIDS or AIDS-related complex. Annals of Internal Medicine, 118(5)
321-330, 1993.
104. Berger, A.R., Arezzo, J.C., Schaumburg, H.H., Skowron, G., Bozzette, S.A. and Soo,
W.: 2',3' dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology,
43:358-62, 1993.
105. Kaplan, J.G., Kessler, J., Rosenberg, N., Pack, D. And Schaumburg, H.H.: Sensory
neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology, 43:2193-2196,
1993.
106. Berger, A.R., Schaumburg, H.H., Gourevitch, M.N., Freeman, K., Herskovitz, S., and Arezzo, J.: Prevalence of peripheral neuropathy in injection drug users. Neurology, 53:592-
597, 1999.
107. Grober, E.H. and Schaumburg, H.H.: High level occupational exposure to methyl isobutyl
ketone causes permanent impairment in working memory. Neurology, 54:1853-1856, 2000.
108. Schaumburg, H.H. and Herskovitz, S.: The weak child - A cautionary tale. The New England
Journal of Medicine, 342:127, 2000.
109. Verghese, J., Bieri, P.L., Gellido, C., Schaumburg, H.H., and Herskovitz, S.: Peripheral
neuropathy in young old and old-old patients. Muscle & Nerve, 24: 1476, 2001.
110. Geyer, H. L., Schaumburg, H.H. and Herskovitz, S.: Methyl bromide intoxication causes
reversible symmetric brainstem and cerebellar MRI lesions. Neurology, 64:1279-1281,
18
2005.
111. Schaumburg, H.H. Thalidomide neuropathy: does dose matter? Journal Watch, 7:14, 2005.
112. Schaumburg, H.H. and Rapin, I.: In memoriam: Labe Scheinberg. Neurology, 64:1836-37,
2005.
113. Schaumburg, H.H. and Albers, J.W.: Pseudoneurotoxic disease. Neurology, 65:22-26, 2005.
114. Schaumburg, H.H., Herskovitz, S. and Cassano, V.: Occupational manganese neurotoxicity
provoked by hepatitis C. Neurology, 67: 322-323.2006.
115. Schaumburg, H.H., Zotova, E., Raine, C.S. et al.: Structural and functional studies of the
murine cavernous nerve: A model system for serial spatio temporal study of autonomic
neuropathy. British Journal of Urology, 99: 916-924, 2007.
116. Schaumburg, H.H., Wade, L. and Masur, D.: Persistent psychosis from toluene exposure:
more likely coincidence than cause. A review of our experience and the literature. Current
Psychiatry Reviews, 3:277-280,2007.
117. Schaumburg, H.H. and Herskovitz, S.: Copper deficiency myeloneuropathy: a clue to
clioquinol induced subacute myelo-optic neuropathy (SMON). Neurology, 71:622-623, 2008.
118. Zotova, E., Schaumburg, H.H., Raine, CS, et al.: Effects of hyperglycemia on rat cavernous
nerve axons: a functional and ultrastructural study. Experimental Neurology, 213:439-447,
2008.
119. Schaumburg, H.H., Gellido, C, Smith, S, Nelson, L. and Hoffman, R.: Elemental mercury
neurotoxicity from self injection. Neurology, 72:377-378, 2009.
120. Schaumburg, H.H., Zotova, E., Raine, CS., et al. The rat caudal nerve: a model for
experimental neuropathies. Jl Peripheral Nervous System, 15:128-139, 2010.
121. Schaumburg, H.H., Arezzo, J.C. Lauria, G., Faber, C.G., Ingeman, S.J., Merkies.
Morphometry of dermal nerve fibers in human skin. Neurology, 77(19):1770-1, 2011
122. Geyer H, Herskovitz S, Slamowitz I, Schaumburg HH. Opto-chiasmatic and peripheral
neuropathy due to ethambutol overtreatment. J Neuropthamol, in press, 2013.
CHAPTERS IN BOOKS AND REVIEW ARTICLES:
1. Schaumburg, H.H. and Scheinberg, L.: A Review of Neurology. Med. Exam. Rev.
Publ. House, pp. 1-153, 1970.
2. Scheinberg, L., Taylor, J. and Schaumburg, H.H.: Handbook of Neurology. Med.
Exam. Publ. Co., pp. 1-210, 1972.
19
3. Schaumburg, H.H. and Schnur, J.: Self-assessment of current knowledge in neurology.
Med. Exam. Publ. Co., pp. 1-150, 1972.
4. Schaumburg, H.H.: Diagnosis, prognosis and treatment of peripheral neuropathies.
Resident and Staff Physician 12:121-125, 1972.
5. Woods, B. and Schaumburg, H.H.: Nigro-spino-dentatal degeneration with nuclear
ophthalmoplegia. In: Handbook of Clinical Neurology, Vol. 22. Edited by Vinken and
Bruyn, pp. 157-176, 1975.
6. Spencer, P.S. and Schaumburg, H.H.: A review of acrylamide neurotoxicology. I.
Properties, uses and human exposure. Canadian Journal of Neurological Sciences. 1:143-
149, 1974.
7. Spencer, P.S. and Schaumburg, H.H.: A review of acrylamide 24.13-neurotoxicity.
Part 2. Experimental animal models of neurotoxicity. Canadian Journal of Neurological
Sciences, 1:152-169, 1974.
8. Raine, C.S. and Schaumburg, H.H.: The neuropathy of myelin diseases of the central
and peripheral nervous system. Chapter 8 of "Myelin." Edited by P. Morell, Plenum
Press, pp. 271-319, 1976.
9. Schaumburg, H.H. and Raine, C.S.: The neurology of myelin diseases of the central
and peripheral nervous system. Chapter 9 of "Myelin." Edited by P. Morell, Plenum
Press, pp. 325-349, 1976.
10. Schaumburg, H.H. and Spencer, P.S.: Pathology of spinal root compression. In:
NINCDS Monograph on the Research Status of Spinal Manipulative Therapy. Edited by
M. Goldstein, NINCDS Monograph, No. 15, DHEW, p. 141, 1975.
11. Schaumburg, H.H., Powers, J., Suzuki, K., Igarashi, M., Johnson, A., Raine, C.S.,
Kolodny, E. and Kishimoto, Y.: Adrenoleukodystrophy - A clinical, histochemical and
biochemical study. In: Current Trends in the Sphingolipidoses and Allied Disorders.
Edited by B. Volk, Plenum Press, 379-389,1976.
12. Spencer, P.S. and Schaumburg, H.H: Central and peripheral distal axonopathy - The
pathology of dying-back polyneuropathies. In: Progress in Neuropathology. Edited by
H.M. Zimmerman, Vol. III, pp. 253, Grune and Stratton, New York 1976.
13. Schaumburg, H.H. and Spencer, P.S.: The neurology and neuropathology of the
occupational neuropathies. Journal of Occupational Medicine, 18:739-742, 1976.
14. Spencer, P.S. and Schaumburg, H.H.: Industrial Neuropathies: In: Neurotoxicology.
Edited by L. Roizin, H. Shirake, and N.Grcevic, Raven Press, New York, pp. 427-430,
1977.
15. Wertenbaker, C. and Schaumburg, H.H.: The treatment of peripheral neuropathy. In:
Current Therapy, 13th
edition. Edited by H.F. Conn, W.B. Saunders, pp. 732-737, 1978.
20
16. Spencer, P.S. and Schaumburg, H.H.: The pathobiology of neurotoxic axonal
degeneration. In: The Physiology and Pathobiology of Axons. Edited by S. Waxman,
New York.
17. Swerdlow, M. and Schaumburg, H.H.: Neurologic Diseases. In: Clinical Medicine for
the Occupational Physician. Edited by M. Alderman, Dekker, 1979.
18. Ogino, T., Schaumburg, H.H., Suzuki, K., Kishimoto, Y. and Moser, A.: Metabolic
studies of adrenoleukodystrophy. In: Myelination and Demyelination. Edited by J.Palo,
Plenum Press, pp. 601-618, 1978.
19. Schaumburg, H.H. and Spencer, P.S.: The toxic neuropathies - A review. Neurology,
29:429-431, 1979.
20. Spencer, P.S., Schaumburg, H.H., Sabri, M.I. and Veronesi, B.: The enlarging view of
hexacarbon
neurotoxicity. CRC Critical Review in Toxicology, 7:278-356, 1980.
21. Kawamura, N., Moser, H.W., Kishimoto, Y., Schaumburg, H.H., Suzuki, K., and
Murphy, J.: Excess C-26 fatty acid in cultured skin fibroblasts from
adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) patients.
Transactions of the American Neurological Association, 103:1-3, 1978.
22. Schaumburg, H.H. and Spencer, P.S.: Toxic models of certain disorders of the nervous
system. Neurotoxicology, 1:209, 1979.
23. Schaumburg, H.H. and Spencer, P.S.: Clioquinol. In: Experimental and Clinical
Neurotoxicology. Edited by P.S. Spencer and H.H. Schaumburg, Williams and Wilkins,
Baltimore, MD, 395-406, 1980.
24. Sterman, A.B. and Schaumburg, H.H.: The neurological exam: A mirror of anatomical
vulnerabilities. In: Experimental and Clinical Neurotoxicology. Edited by P.S. Spencer
and H.H. Schaumburg, Williams and Wilkins, Baltimore, MD, 675-680, 1980.
25. Sterman, A.B. and Schaumburg, H.H.: Neurotoxicity of selected drugs. In:
Experimental and Clinical Neurotoxicology. Edited by P.S. Spencer and H.H.
Schaumburg, Williams and Wilkins, Baltimore, MD, 593-612, 1980.
26. Landau, N. and Schaumburg, H.H.: Compensation in the United States for victims of
neurotoxic injury: The Plaintiff's perspective. In: Experimental and Clinical
Neurotoxicology. Edited by P.S. Spencer and H.H. Schaumburg, Williams and Wilkins,
Baltimore, MD, 890-898, 1980.
27. Politis, M., Schaumburg, H.H. and Spencer, P.S.: Neurotoxicity of selected chemicals.
In: Experimental and Clinical Neurotoxicology. Edited by P.S. Spencer and H.H.
Schaumburg, Williams and Wilkins, Baltimore, MD, 613-630, 1980.
28. Spencer, P.S., Couri, D. and Schaumburg, H.H.: n-Hexane and methyl n-butyl ketone.
21
In: Experimental and Clinical Neurotoxicology. Edited by P.S. Spencer and H.H.
Schaumburg, Williams and Wilkins, Baltimore, MD, 456-475, 1980.
29. Sterman, A.B. and Schaumburg, H.H.: The peripheral neuropathy of aging: Basic and
functional changes. In: Physicians Progress. Edited by R.K. Katzman, Physicians
Progress Press, New York, 1980.
30. Schaumburg, H.H.: Aspects of hexacarbon neurotoxicity - A review. In: Progress in
Neurotoxicology. Edited by L. Manzo, Pergamon Press, Oxford, England, 1980.
31. Spencer, P.S. and Schaumburg, H.H.: Neurotoxic chemicals as probes of cellular
mechanisms of neuromuscular disease. In: Current Topics in Nerve and Muscle
Research. Edited by A. Aguayo and G. Kaplan, North Holland, 274, 1979.
32. Schaumburg, H.H. and Spencer. P.S.: Toxic models of disorders of the peripheral
nervous system. In: Current Topics in Nerve and Muscle Research . Edited by A.Aguayo
and G.Kaplan, North Holland, 265, 1979.
33. Spencer, P.S. and Schaumburg, H.H.: Classification of neurotoxic disease: A
morphological approach. In: Experimental and Clinical Neurotoxicology, . Edited by
P.S. Spencer and H.H. Schaumburg, Williams and Wilkins, Baltimore, MD, 92-99, 1980.
34. Spencer, P.S. and Schaumburg, H.H.: Selected outbreaks of neurotoxic disease: In:
Experimental and Clinical Neurotoxicology. Edited by P.S. Spencer and H.H.
Schaumburg, Williams and Wilkins, Baltimore, MD, 883-889,
1980.
35. Spencer, P.S., Schaumburg, H.H. and Bischoff, M.C.: Neuropathological methods for
the detection of neurotoxic disease. In: Experimental and Clinical Neurotoxicology.
Edited by P.S. Spencer and H.H. Schaumburg, Williams and Wilkins, Baltimore, MD,
743-757, 1980.
36. Schaumburg, H, H. and Spencer, P.S.: Peripheral neuropathy update. In: Current
Neurology. Edited by S. Appel, Houghton-Mifflin, Boston, MA, 1981.
37. Spencer, P.S., Politis, M.J., Pellegrino, R.G. and Schaumburg, H.H.: The cellular target
site in distal axonopathies. In: Diseases of the Motor Unit. Edited by D.L. Schotland,
John Wiley & Sons, N.Y., pp. 87-101, 1982.
38. Schaumburg, H.H., Spencer, P.S. and Ochoa, J.: The aging human peripheral nervous
system. In: Neurology of Aging. Edited by R. Katzman and R. Terry, Contemporary
Neurology Series, F.A. Davis, Philadelphia, pp. 11-122, 1983.
39. Schaumburg, H.H.: Chronic hexacarbon intoxication in man. In: Advances in
Neurotoxicology. Edited by Manzo, Pergamon Press, New York, pp. 70-78, 1980.
40. Schaumburg, H.H. and Spencer, P.S.: Human toxic neuropathy due to industrial agents.
Peripheral Neuropathy, Vol. 2, Edited by P. Dyck, P.K. Thomas, E.H. Lambert and R.
Bunge, Saunders Co., Philadelphia, PA, 1981.
22
41. Spencer, P.S. and Schaumburg, H.H.: Experimental models of primary axonal disease
induced by toxic chemicals. In: Peripheral Neuropathy, Vol. 2. Edited by P. Dyck, P.K.
Thomas, E.H. Lambert, and R. Bunge, Saunders Co., Philadelphia, PA, 1981.
42. Spencer, P.S., Arezzo, J.C. and Schaumburg, H.H.: Chemical causing disease of
neurons and their processes. In: Neurotoxicity of Industrial and Commercial Chemicals.
Edited by J.O'Donoghue), CRC Press, 1982.
43. Schaumburg, H.H., Spencer, P.S. and Thomas, P.K.: Disorders of Peripheral Nerve. In:
Contemporary Neurology Series Number 24. F.A. Davis, Philadelphia, PA, 1983.
44. Schaumburg, H.H., Arezzo, J., Markowitz, L. and Spencer, P.S.: A critical review of
neurotoxicity assessment: The situation at chemical disposal sites. In: Assessment of
Health Effects at Chemical Disposal Sites. Edited by W. Lorance, Wm. Kaufman and
Co., Los Altos, pp. 82-105, 1983.
45. Schaumburg, H.H. and Powers, J.: Clinical and pathological features of
adrenoleukodystrophy. A review. Jap. J. of Neuropathology (Suppl), 203-208, 1983.
46. Spencer, P.S. and Schaumburg, H.H.: The pathogenesis of motor neuron disease:
Perspectives from neurotoxicology. Conference on Human Motor Neuron Diseases.
Edited by L.P. Rowland, Raven Press, p. 251-268, 1982.
47. Spencer, P.S. and Schaumburg, H.H.: Lathyrism: A model of pyramidal-tract
degeneration. In: Progress in Motor Neuron Disease. Edited by F. Clifford Rose, Pitman
Medical Publishers, London, 1983.
48. Schaumburg, H.H.: Diseases of Peripheral Nerves and Nerve Roots. In: Chapters 524-
535. Cecil Textbook of Medicine, 17th Edition, 1985.
49. Spencer, P.S., Schaumburg, H.H. and Arezzo, J.: Chemicals causing disease of neurons
and their processes. In: Neurotoxicology of Industrial and Commercial Chemicals. Vol.
1, CRC Press, pp. 1-14, 1984.
50. Arezzo, J.C., Schaumburg, H.H. and Laudadio, C.: Thermal sensitivity tester. Device
for quantitative assessment of thermal sense in diabetic neuropathy. Diabetes, 35(5):
590-592, 1976.
51. Schaumburg, H.H. and Spencer, P.S.: Chemical Neurotoxicity in Diseases of the
Nervous System. Edited by A. K .Asbury, G. McKhan and W. I. McDonald. W.B.
Saunders, pp. 1303-1315, 1986.
52. Schaumburg, H.H.: Diseases of Peripheral Nerves and Nerve Roots. Cecil Textbook of
Medicine, 18th Edition, 1991.
53. Schaumburg, H.H. and Berger, A.: The Neurotoxicity of Pyridoxine. In: Current
Topics in Nutrition and Disease. Vol. 15. Edited by D. Scarpelli and G. Migaki, Alan
Liss, pp. 319-328, 1986.
23
54. Schaumburg, H.H. and Spencer, P.S.: Recognizing neurotoxic disease. Neurology,
37:276-278, 1987.
55. Spencer, P.S., Hugon, J., Ludolph, A., Nunn, P.B., Ross, S.M., Roy, D.N. and
Schaumburg, H.H.: Discovery and Partial Characterization of Primate-Motor System
Toxins. In: Selective Neuronal Death. Ciba Foundation Symposium 126. John Wiley &
Sons, New York, pp. 221-238, 1987.
56. Schaumburg, H.H. and Berger, A.: Pyridoxine Neurotoxicity. In: Clinical and
Physiological Applications of Vitamin B-6. Alan R. Liss, Inc., 403-413, 1988.
57. Schaumburg, H.H., Berger, A. and Thomas, P.K.: Disorders of Peripheral Nerves. 2nd
Edition, F.A. Davis, Philadelphia, 1991.
58. Schaumburg, H.H.: Chemical Neurotoxicity. In: Diseases of the Nervous System, 2nd
Edition. Edited by Asbury, McKann, McDonald, W.B. Saunders, Philadelphia, 1992.
59. Schaumburg, H.H. and Berger, A.: Human Toxic Neuropathy from Industrial Agents.
In: Peripheral Neuropathy - 3rd Edition. Edited by Dyck, Thomas, Griffin and Low,
W.B. Saunders, Philadelphia, pp. 1533-48, 1992.
60. Grober, E., Crystal, H., Lipton, H. and Schaumburg, H.: Author's Commentary. EtO is
Associated with Cognitive Dysfunction. Brief Communication. Journal of Occupational
Medicine. 34(11):1114-1115, November 1992.
61. Herskovitz, S. and Schaumburg, H.: Neuropathy due to Drugs. In: Peripheral Neuropathy –4th
Edition. Edited by Dyck, Thomas, Griffin, and Low, Elsevier Science, Philadelphia, pp 2553-
2583, 2005.
62. Berger, A., Schaumburg, H.: Neuropathy due to Industrial Agents. In: Peripheral Neuropathy-
4th
Edition. Edited by Dyck, Thomas, Griffin, and Low, Elsevier Science, Philadelphia, pp2505-
2527, 2005.
63. Schaumburg, H.H. and Albers, J.W.: Identification of Neurotoxic Disease. In: Continuum
Neurotoxicology, vol. 14, pp11-34, 2008.
64. Herskovitz, S., Scelsa, S., and Schaumburg, H.H.: Peripheral Neuropathies in Clinical Practice.
In: Contemporary Neurology Series, Oxford Univ. Press, 2009.
65. Arezzo, J.C., Seto, S. and Schaumburg, H.H.: Sensory-motor assessment in clinical research
trials. Handb Clin Neurol. 115:265-78, 2013.
